# P5P (Pyridoxal-5-Phosphate)

> P5P is the active coenzyme form of vitamin B6, immediately usable by the body without conversion. It serves as a key cofactor for DAO, the enzyme that breaks down histamine, making it critical for MCAS, and it supports neurotransmitter synthesis for autonomic regulation. ZebraThrive uses 50 mg daily.

**Page:** https://www.wellnessforzebras.com/ingredients/p5p
**Brand:** ZebraThrive
**Author:** Ken Chapman, Founder of ZebraThrive
**Last reviewed:** 2026-05-11
**Daily dose:** 50 mg daily
**Form used:** P5P (Pyridoxal-5-Phosphate)
**Target population:** Adults 18+ with hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), or Mast Cell Activation Syndrome (MCAS).
**Regulatory framing:** US DSHEA dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

## Key benefits

- Supporting cofactor for amine metabolism enzymes; relevant for histamine pathway handling
- Supports GABA, serotonin, and dopamine synthesis
- NO neuropathy risk unlike standard pyridoxine HCl
- Bypasses genetic conversion polymorphisms

## What it is

The active, coenzyme form of vitamin B6 that is immediately usable by the body

## Why we include it

Essential cofactor for DAO enzyme (histamine degradation)-critical for MCAS; supports neurotransmitter synthesis for autonomic regulation

## Plain-language summary

P5P is the active, phosphorylated form of vitamin B6 - the form your enzymes can use directly. For the triad, P5P is one of the most directly MCAS-relevant B vitamins on the list: it's the essential cofactor for DAO (diamine oxidase), the primary enzyme that breaks down histamine in your gut. German clinical research has shown that adequate B6 (over 20 µg/L) increases histamine elimination by 20% when DAO is supplemented. P5P also supports neurotransmitter synthesis (GABA, serotonin, dopamine) - relevant for autonomic regulation in POTS. We dose 50 mg in the AM.

## Mechanism

P5P is the biologically active form of B6. Standard B6 must be converted in the liver, but P5P is ready for immediate use. For MCAS, P5P is a supporting cofactor for several amine-metabolism enzymes including histidine decarboxylase. DAO itself, the enzyme that breaks down histamine in the gut, is primarily copper-dependent (with TPQ as its organic cofactor); adequate B6 status supports the broader amine pathway that DAO operates within.

Beyond histamine, P5P is required for synthesis of GABA, serotonin, and norepinephrine-critical for autonomic regulation in POTS. It is involved in over 100 enzymatic reactions, including those that convert excitatory glutamate to calming GABA.

## Condition-specific notes

### MCAS (Mast Cell Activation Syndrome)

Primary indication as a DAO cofactor. Supports the pathway that clears histamine after degranulation. Unlike standard B6 (pyridoxine), P5P does not carry the risk of peripheral neuropathy. The 'B6 Paradox' is avoided by using the active form directly.

### hEDS (hypermobile Ehlers-Danlos Syndrome)

Indirect support via homocysteine metabolism. Deficiency leads to elevated homocysteine, which inhibits collagen crosslinking via LOX inhibition. P5P helps counteract this inhibition and supports crosslink quality.

### POTS (Postural Orthostatic Tachycardia Syndrome)

Supports synthesis of neurotransmitters essential for autonomic balance (GABA, norepinephrine). Deficiency is common (up to 47% in some studies) and is associated with autonomic neuropathy and fainting frequency.

## Why this form

**Selected form:** P5P (Pyridoxal-5-Phosphate)

Pyridoxine HCl can cause peripheral neuropathy and the 'B6 Paradox' (functional deficiency with high blood levels). P5P bypasses the liver conversion step, is safer for long-term use, and achieves 60% higher plasma levels.

**Form comparison:**

| Form | Notes | Selected |
|---|---|---|
| P5P (Pyridoxal-5-Phosphate) | Active form; no conversion needed; NO neuropathy risk | Yes |
| Pyridoxine HCl | Neuropathy risk at doses as low as 2mg; conversion dependent | No |

## Dose protocol

| Step | Dosage | Notes |
|---|---|---|
| Weeks 1-2 | 25 mg daily | Conservative start |
| Week 3+ | 50 mg daily | Standard target dose for DAO support |

**Timeline to effect:** Histamine tolerance improvements often noticeable within 2-4 weeks. Take in the AM with breakfast.

## Evidence summary

### DAO Cofactor Function

Essential for the activity of the primary histamine-degrading enzyme.

- **Clinical Chemistry (2024).** Finding: B6 levels >20 μg/L showed 20% increased histamine elimination with DAO..
- [1] **Maintz & Novak.** Finding: Deficiency reduces DAO activity by up to 50%; P5P is critical for degradation.. PMID: 17490952.

### Mast Cell Stabilization

Direct suppression of mast cell activity, synergistic with vitamin C.

- [2] **Kazama et al..** Finding: Dose-dependent suppression of mast cell activation; cromolyn-like profile.. PMID: 35781358.

### Autonomic Support

Improved sympathetic-parasympathetic balance and reduced syncope frequency.

- [6] **Kovalchuk.** Design: Human study, 68 patients. Finding: B6 supplementation significantly reduced syncope frequency.. PMID: 40134906.
- [7] **Cui et al..** Finding: Demonstrated reduced sympathetic activity and improved HRV restoration.. PMID: 21078590.

## Evidence gaps

No direct RCTs in hEDS or POTS populations. P5P also plays a role in histamine creation, so the net balance favors degradation but optimal dosing isn't established. Misconception exists: P5P is NOT a direct LOX cofactor (copper is).

## Safety

**Side effects:** Excellent safety. No neuropathy risk even at high (750mg) doses. May cause vivid dreams if taken before bed.

**Interactions:** CONTRAINDICATED with Levodopa without carbidopa. Anticonvulsants may require monitoring. Synergistic with Magnesium, Zinc, and Vitamin C.

**Cautions:** Requires cool, dry storage as it is less stable than pyridoxine HCl. Target >20 μg/L serum levels for optimal DAO support.

**Excipients to avoid:** Artificial colors, Citric acid, Corn dextrose, Magnesium stearate

**Excipients that are safe:** Cellulose, Rice flour, Minimal-excipient formulations

## Frequently asked questions

### Why P5P instead of regular B6?

P5P is the active, phosphorylated form your enzymes use directly - no liver conversion required. Regular pyridoxine has to be converted to P5P, and that conversion can be impaired in chronic illness or genetic variants. Crucially, high-dose pyridoxine has been linked to peripheral neuropathy at doses as low as 50 mg/day in sensitive individuals. P5P has no documented neuropathy risk even at much higher doses. For long-term daily use in a sensitive population, the active form is the safe form.

### How does P5P help with histamine?

Through amine metabolism support. P5P is a coenzyme for histidine decarboxylase and several other enzymes in the amine pathways that handle histamine and related compounds. DAO itself, the enzyme that breaks histamine down in your gut, is primarily copper-dependent (with TPQ as its organic cofactor) rather than B6-dependent. That said, B6 status does correlate with histamine clearance in observational data: a 2024 Clinical Chemistry study showed B6 levels over 20 µg/L produced about 20% better histamine clearance than deficient levels. The mechanism is upstream support of the broader amine pathway DAO operates within, not direct DAO cofactoring.

### Does P5P stabilize mast cells directly?

There's moderate evidence. A 2022 study (Kazama) showed P5P produces dose-dependent mast cell suppression, synergistic with vitamin C. An older 1979 study (García) reported a cromolyn-like mast cell stabilizing profile. The mechanism likely involves both direct mast cell membrane effects and broader support of amine metabolism. We don't lead with mast cell stabilization for P5P; the indirect amine-pathway work is the stronger evidence base, but the direct effect is documented.

### Will P5P interact with my medications?

P5P at 50 mg has minimal documented interactions. The main one to know: levodopa (for Parkinson's). High-dose B6 increases the conversion of levodopa to dopamine before it can cross the blood-brain barrier, reducing its effectiveness. Carbidopa blocks this interaction, so if you're on Sinemet (carbidopa/levodopa), the interaction is manageable. Some antiepileptics may slightly lower B6 levels over time. For standard POTS, MCAS, and hEDS medications, P5P is a clean addition.

## References

[1] Maintz L, Novak N. (2007). Histamine and histamine intolerance (DAO/B6 review). PMID: 17490952. https://pubmed.ncbi.nlm.nih.gov/17490952/
[2] Kazama et al.. (2022). P5P mast cell suppression, vitamin C synergy. PMID: 35781358. https://pubmed.ncbi.nlm.nih.gov/35781358/
[3] Hadtstein F, Vrolijk M. (2021). The B6 paradox: pyridoxine disrupts GABA and cause neuropathy. PMID: 33912895. https://pubmed.ncbi.nlm.nih.gov/33912895/
[4] EFSA. (2023). Updated B6 safety and upper limits. PMID: 37207271. https://pubmed.ncbi.nlm.nih.gov/37207271/
[5] Saito M et al.. (2006). Pyridoxal and collagen crosslinks in hip fracture. PMID: 16969591. https://pubmed.ncbi.nlm.nih.gov/16969591/
[6] Kovalchuk. PMID: 40134906. https://pubmed.ncbi.nlm.nih.gov/40134906/
[7] Cui et al.. PMID: 21078590. https://pubmed.ncbi.nlm.nih.gov/21078590/